Literature DB >> 11395191

Epidemiologic Study of Pseudomonas aeruginosa in critical patients and reservoirs.

A L Corona-Nakamura1, M G Miranda-Novales, B Leaños-Miranda, L Portillo-Gómez, A Hernández-Chávez, J Anthor-Rendón, S Aguilar-Benavides.   

Abstract

BACKGROUND: Pseudomonas aeruginosa is a common cause of nosocomial infections, particularly in intensive care units (ICUs). The aim of this study was to characterize P. aeruginosa clinical isolates by comparing antimicrobial susceptibility patterns with the presence of plasmids and to establish the clonal relatedness by pulsed-field gel electrophoresis (PFGE) typing.
METHODS: The patients included those with isolation of P. aeruginosa hospitalized for more than 48 h in the ICU from April to May 1998. Environmental and staff cultures were obtained simultaneously. Minimal inhibitory concentrations, plasmid DNA profiles, and PFGE genomic patterns of enzyme restriction chromosomal DNA were compared.
RESULTS: Sixty P. aeruginosa isolates were obtained from 197 clinical specimens, 178 environmental samples, and 47 hand cultures of personnel. Antimicrobial resistance was as follows: tobramycin 100%; ticarcillin, cefotaxime, ceftriaxone, ceftazidime, and gentamicin 80%; cefepime 60%; amikacin, ticarcillin/clavulanate, imipenem, and meropenem 40%; piperacillin and norfloxacin 20%; carbenicillin 12%, and ciprofloxacin 0%. Plasmids were detected in 11 isolates (18%). PFGE typing showed that 23 isolates belonged to a common clone (pattern A), identified from five patients, two nurses, and 10 environmental samples. Ten isolates were grouped in four clusters and 27 isolates had unrelated genomic patterns. There was no relationship among DNA genomic patterns, plasmid profiles, and susceptibility patterns.
CONCLUSIONS: PFGE demonstrated the existence of a common clone in a critical care area. Reinforcement of infection control measures is needed to avoid horizontal transmission and severe infections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11395191     DOI: 10.1016/s0188-4409(01)00267-3

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  7 in total

1.  Plasmid Profile Analysis and bla VIM Gene Detection of Metalo β-lactamase (MBL) Producing Pseudomonas aeruginosa Isolates from Clinical Samples.

Authors:  Jayanthi S; Jeya M
Journal:  J Clin Diagn Res       Date:  2014-06-20

2.  Rapid identification of Pseudomonas aeruginosa by pulsed-field gel electrophoresis.

Authors:  Samy Selim; Iman El Kholy; Nashwa Hagagy; Sahar El Alfay; Mohamed Abdel Aziz
Journal:  Biotechnol Biotechnol Equip       Date:  2014-11-18       Impact factor: 1.632

3.  Combination antibiotics against Pseudomonas aeruginosa, representing common and rare cystic fibrosis strains from different Irish clinics.

Authors:  Priya Kapoor; Philip Murphy
Journal:  Heliyon       Date:  2018-03-08

4.  Fingerprint Analysis and Identification of Strains ST309 as a Potential High Risk Clone in a Pseudomonas aeruginosa Population Isolated from Children with Bacteremia in Mexico City.

Authors:  Rosario Morales-Espinosa; Gabriela Delgado; Luis F Espinosa; Dassaev Isselo; José L Méndez; Cristina Rodriguez; Guadalupe Miranda; Alejandro Cravioto
Journal:  Front Microbiol       Date:  2017-03-01       Impact factor: 5.640

5.  Molecular epidemiology of Pseudomonas aeruginosa in University Clinical Center of Kosovo.

Authors:  Greta Lila; Gjyle Mulliqi; Lul Raka; Arsim Kurti; Rrezarta Bajrami; Elvir Azizi
Journal:  Infect Drug Resist       Date:  2018-10-26       Impact factor: 4.003

6.  Pseudomonas aeruginosa infections in patients, hospital means, and personnel's specimens.

Authors:  Hossein Fazeli; Reza Akbari; Sharareh Moghim; Tahmineh Narimani; Mohammad Reza Arabestani; Ali Reza Ghoddousi
Journal:  J Res Med Sci       Date:  2012-04       Impact factor: 1.852

7.  Infectious conjunctivitis caused by Pseudomonas aeruginosa isolated from a bathroom.

Authors:  Hiroshi Eguchi; Tatsuro Miyamoto; Tomomi Kuwahara; Sayaka Mitamura; Yoshinori Mitamura
Journal:  BMC Res Notes       Date:  2013-07-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.